Usana Health Sciences (USNA) Revenue (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Revenue data on file, last reported at $250.2 million in Q2 2026.

• On a quarterly basis, Revenue changed 0.27% year-over-year to $250.2 million in Q2 2026; TTM through Apr 2026 was $925.9 million, a 5.67% increase from a year earlier, with the FY2026 full-year figure at $925.3 million, up 8.28% from the prior year.
• Revenue for Q2 2026 stood at $250.2 million, up from $226.2 million in the prior quarter.
• Over the last five years, Revenue for USNA reached as high as $362.3 million in Q1 2022 and fell as low as $200.2 million in Q3 2024.
• Historically, Revenue has averaged $239.6 million across 5 years, with a median of $230.6 million in 2022.
• Across the five-year window, Revenue sank 37.09% in 2022 and gained 10.79% in 2025, its largest moves.
• Year by year, Revenue stood at $228.0 million in 2022, then dropped by 3.02% to $221.1 million in 2023, then declined by 3.38% to $213.6 million in 2024, then grew by 0.03% to $213.7 million in 2025, then increased by 17.1% to $250.2 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $250.2 million in Q2 2026, $226.2 million in Q1 2026, and $213.7 million in Q3 2025.